Precigen, Inc. Selling, General and Administrative Expense of Revenue

Selling, General and Administrative Expense of Revenue of PGEN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Selling, General and Administrative Expense of Revenue growth rates and interactive chart.


Highlights and Quick Summary

  • Selling, General and Administrative Expense of Revenue for the quarter ending June 30, 2022 was 435.25% (a 612.01% increase compared to previous quarter)
  • Year-over-year quarterly Selling, General and Administrative Expense of Revenue increased by 402.89%
  • Annual Selling, General and Administrative Expense of Revenue for 2021 was 71.36% (a -19.71% decrease from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2020 was 88.88% (a -18.25% decrease from previous year)
  • Annual Selling, General and Administrative Expense of Revenue for 2019 was 108.72% (a 30.7% increase from previous year)
  • Twelve month Selling, General and Administrative Expense of Revenue ending June 30, 2022 was 90.09% (a 25.37% increase compared to previous quarter)
  • Twelve month trailing Selling, General and Administrative Expense of Revenue increased by 2.04% year-over-year
Trailing Selling, General and Administrative Expense of Revenue for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
90.09% 71.86% 76.21% 88.29%
Visit stockrow.com/PGEN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Selling, General and Administrative Expense of Revenue of Precigen, Inc.

Most recent Selling, General and Administrative Expense of Revenueof PGEN including historical data for past 10 years.

Interactive Chart of Selling, General and Administrative Expense of Revenue of Precigen, Inc.

Precigen, Inc. Selling, General and Administrative Expense of Revenue for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 435.25% 61.13%
2021 90.03% 86.55% 59.55% 76.3% 71.36%
2020 155.38% 94.6% 58.73% 72.01% 88.88%
2019 153.79% 121.25% 58.62% 137.48% 108.72%
2018 36.37% 119.29% 76.04% 100.18% 83.18%
2017 26.7% 85.36% 71.36% 65.38% 62.13%
2016 76.87% 69.03% 57.64% 98.72% 74.54%
2015 83.71% 43.13% 52.73% 81.62% 62.82%
2014 63.61% 70.07% 130.5% 173.61% 88.49%
2013 172.15% 122.59% 111.12% 166.8% 141.49%
2012 172.51% 232.32% 180.75%
2011 228.38%

Business Profile of Precigen, Inc.

Sector: Healthcare
Industry: Biotechnology